Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Study Information
Alliance Study ID: NCCTG-N9951
NCT Study ID (ClinicalTrials.gov): NCT00005828
Disease or Cancer Type: Prostate Cancer
Alliance Study Chair: Aminah Jatoi, MD
Status: COMPLETED
Study Description
RATIONALE: Green tea extract contains substances that may slow the growth of certain cancers and may prevent the development of new cancers.
PURPOSE: Phase II trial to determine the effectiveness of green tea extract in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information